Novel C-organosilicon derivatives as leads for reverse-transcriptase-mediated anti-HIV-1 activity

Author： Delord B.   Guillorit M.   Lafay J.   Andreola M.   Tharaud D.   Tarrago-Litvak L.   Fleury H.   Deleris G.  

Publisher： Elsevier

ISSN： 0223-5234

Source： European Journal of Medicinal Chemistry, Vol.31, Iss.2, 1996-01, pp. : 111-122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthesis and Anti-HIV Evaluation of Novel 1,2,4-triazole Derivatives as Potential Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 1, 2013-01 ,pp. : 27-34

Bentham Science Publishers

Access to resources Recommend Favorite

A Nanoparticle-Encapsulated Non-Nucleoside Reverse-Transcriptase Inhibitor with Enhanced Anti-HIV-1 Activity and Prolonged Circulation Time in Plasma

By  

Current Pharmaceutical Design, Vol. 21, Iss. 7, 2015-02 ,pp. : 925-935

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Thiazolidinone Derivatives with an Uncommon Mechanism of Inhibition Towards HIV-1 Reverse Transcriptase

By  

Letters in Drug Design & Discovery, Vol. 7, Iss. 4, 2010-05 ,pp. : 228-234

Bentham Science Publishers

Access to resources Recommend Favorite

Combinations Against Combinations: Associations of Anti-HIV 1 Reverse Transcriptase Drugs Challenged by Constellations of Drug Resistance Mutations

By  

Current Drug Metabolism, Vol. 3, Iss. 1, 2002-02 ,pp. : 73-95

Bentham Science Publishers

Access to resources Recommend Favorite

Antiviral activity of 4-benzyl pyridinone derivatives as HIV-1 reverse transcriptase inhibitors

By Andreola Marie-Line   Nguyen Chi Hung   Ventura Michel   Tarrago-Litvak Laura   Legraverend Michel  

Expert Opinion on Emerging Drugs, Vol. 6, Iss. 2, 2001-10 ,pp. : 225-238

Informa Healthcare

Access to resources Recommend Favorite